MTOR and clear cell renal carcinoma: The association between TLS and mutations in the PI3K‐mTOR pathway in renal clear cell carcinoma [7], BRAF mutations in colorectal carcinoma [18], and APC germline mutations in hepatoblastoma [24] has been reported in studies.